Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-25-000107

Co-Chief Executive Officer acquired 74,545 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-30 Exercise or conversion : show line 1 in the form +74,545 $2.64 $196,799 555,754,696 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-30 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −74,545 0 I
Loading xslF345X05/wk-form4_1748898068.xml…